Skip to main content

Kelly Thomas Patrick

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Kelly Thomas Patrick as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

DCPH Deciphera Pharmaceuticals, Inc.

Chief Financial Officer9 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 20, 2024 (view filing)Feb 164 daysKelly Thomas PatrickChief Financial OfficerSSale−3.01K$15.62−$47.0K−3.6%80.3K after
Jan 18, 2024 (view filing)Jan 162 daysKelly Thomas PatrickChief Financial OfficerSSale−2.44K$14.47−$35.2K−3.6%66.1K after
Dec 14, 2023 (view filing)Dec 131 dayKelly Thomas PatrickChief Financial OfficerSSale−2.79K$15.37−$42.9K−3.9%68.5K after
Oct 31, 2023 (view filing)Oct 301 dayKelly Thomas PatrickChief Financial OfficerSSale−2.32K$12.02−$27.8K−3.5%63.1K after
Jun 21, 2023 (view filing)Jun 165 daysKelly Thomas PatrickChief Financial OfficerSSale−1.66K$14.40−$23.8K−2.8%57.1K after
Feb 17, 2023 (view filing)Feb 161 dayKelly Thomas PatrickChief Financial OfficerSSale−1.37K$15.10−$20.7K−2.3%58.8K after
Jan 19, 2023 (view filing)Jan 172 daysKelly Thomas PatrickChief Financial OfficerSSale−2.40K$21.24−$51.0K−5.2%43.7K after
Jun 21, 2022 (view filing)Jun 165 daysKelly Thomas PatrickChief Financial OfficerSSale−1.77K$10.75−$19.0K−3.7%46.1K after
Feb 18, 2022 (view filing)Feb 162 daysKelly Thomas PatrickChief Financial OfficerSSale−1.37K$9.05−$12.4K−2.8%47.8K after